APP and Alzheimer disease: The compound was able to reverse learning and memory impairments in a transgenic mouse model of AD and restored cAMP, p-PKA, p-CREB, and brain-derived neurotrophic factor levels in the hippocampus of APP/PS1 transgenic mice.